DOCSLIB.ORG

Global Vaccination Summit Brussels, 12 September 2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Global Vaccination Summit Brussels, 12 September 2019 GLOBAL VACCINATION SUMMIT BRUSSELS, 12 SEPTEMBER 2019 Charlemagne Building, Rue de la Loi/Wetstraat 170, 1040 Brussels AGENDA 08.00 Registration 09.00 Welcome – Opening Remarks In the presence of Her Majesty the Queen of the Belgians • Jean Claude Juncker, President of the European Commission • Video message Henrietta Fore, Executive Director of the United Nations Children’s Fund • Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization 09.40 Special Address • Yvonne Chaka Chaka, South African singer, champion for the Global Fund to Fight AIDS, TB and Malaria, and the United Nations MDG Envoy for Africa 10.00 Coffee/Tea Break 10.30 In Vaccines we trust: Stepping up action to increase vaccine confidence Chair: Vytenis Andriukaitis, Commissioner for Health and Food Safety, European Commission Panel Members: • Maggie De Block, Minister of Social Affairs and Public Health, and Asylum and Migration, Belgium • Professor Laetitia Rispel, President, World Federation of Public Health Associations • Dr. Zsuzsanna Jakab, Deputy Director General World Health Organization • Dr. Jerome Adams, Surgeon General of the United States Video message Beatrice Vio, Italian wheelchair fencer, 2014 and 2016 European champion, 2015 and 2017 World champion, and 2016 Paralympic champion • Dr. Heidi J. Larson, Director of The Vaccine Confidence Project • Maud Sacquet, Public Policy Manager, Mozilla • Jason Hirsch, Public Policy Manager, Facebook Questions and Answers 11.45 Special Address • Ethan Lindenberger, American teenager known for his opposition to anti-vaccine disinformation campaigns • Fergal and Kevin Brennan, brothers of Laura Brennan, Irish HPV vaccine advocate who died of cervical cancer in March 2019 12.15 The Magic of Science: Boosting vaccine Research, Development, and Innovation Chair: Carlos Moedas, Commissioner for Research, Science and Innovation, European Commission Panel Members: • Professor Stewart Cole, President, Pasteur Institute • Dr. Soumya Swaminathan, Chief Scientist, World Health Organization • Dr. Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations • Nanette Cocero, Vaccines Europe (Global President, Vaccines Pfizer Biopharmaceuticals Group) • Dr. Michael Makanga, Director, European & Developing Countries Clinical Trials Partnership Questions and Answers 13.30 Lunch 15.00 Video Message Federica Mogherini, High Representative of the Union for Foreign Affairs and Security Policy / Vice-President of the European Commission , 15.15 Vaccines Protecting Everyone, Everywhere: Galvanizing a global response to assure health, security and prosperity through immunization Chair: Dr. Peter Salama, Executive Director, Universal Health Coverage / Life Course, World Health Organization Panel members: • Jakaya Mrisho Kikwete, Ambassador, Gavi, the Vaccine Alliance, and Former President of the United Republic of Tanzania • Dr. Elhadj As Sy, Secretary General, International Federation of Red Cross and Red Crescent Societies • Dr. Stefan Swartling Peterson, Chief of Health Section, United Nations Children’s Fund • Dr. Seth Berkley, CEO, Gavi, the Vaccine Alliance • Soraya Narfeldt, CEO, RA International • Joe Cerrell, Managing Director for Global Policy and Advocacy, Bill & Melinda Gates Foundation • Marjeta Jager, Deputy Director General, Directorate-General for International Cooperation and Development, European Commission Questions and Answers 16.30 Closing Remarks and Conclusions of the Summit 17.00 End of Summit #VaccinationSummit19 #VaccinesWork.
Load more

Recommended publications
  • Tuesday, September 24, 2019 Time: 6:00Pm – 8:00Pm Location: Delegates Dining Room (Private Dining Rooms 6 – 8) Please Email [email protected] to RSVP
    The World Health Organization, the United Nations Development Programme and the Global Fund are pleased to invite you to a Side-Event to the High-Level Meeting on Universal Health Coverage: Anti-Corruption, Transparency and Accountability in Health. A multi-sectoral panel discussion will explore the impact of corruption on achieving Sustainable Development Goal (SDG) 3, ensuring healthy lives and promoting wellbeing for all, with a specific focus on SDG 3.8, achieving universal health coverage (UHC). The discussion will consider how the ongoing establishment of an Anti-Corruption, Transparency and Accountability for Health Alliance (ACTA) can leverage its multi-stakeholder platform to foster coordination and collaboration, provide normative guidance to assist countries in developing strategies and partnerships to prevent health sector corruption, and contribute to interventions that strengthen the global pledge to leave no one behind. Date: Tuesday, September 24, 2019 Time: 6:00pm – 8:00pm Location: Delegates Dining Room (Private Dining Rooms 6 – 8) Please email [email protected] to RSVP. Due to limited seating, please confirm your attendance no later than Thursday, 19 September 2019. AGNÉS SOUCAT Director for Health Systems, Governance and Financing World Health Organization MANDEEP DHALIWAL DR. PETER SALAMA MARIJKE WIJNROKS Director of HIV, Health and Executive Director, Universal Health Coverage Chief of Staff Development Practice Life Course The Global Fund United Nations Development Programme World Health Organization JILLIAN KOHLER ALLAN MALECHE Professor, Leslie Dan Faculty of Pharmacy Executive Director University of Toronto KELIN DIWA SAMAD WILLIAM SAVEDOFF Deputy Minister of Policy and Planning Senior Fellow Ministry of Public Health Center for Global Development Afghanistan Mandeep Dhaliwal Director, HIV, Health and Development Team, Bureau of Policy and Programme Support United Nations Development Programme Mandeep Dhaliwal is the Director of UNDP’s HIV, Health and Development Group, Bureau of Policy and Programme Support.
    [Show full text]
  • Bulletin of the World Health Organization
    News WHO’s new emergencies programme bridges two worlds Peter Salama tells Fiona Fleck how the World Health Organization’s (WHO) new emergencies programme is changing the way the agency helps countries prepare for and respond to health crises. Q: WHO’s new health emergencies programme aims to create one single Peter Salama is leading the World Health Organization’s programme, with one workforce, one (WHO) efforts to reform its emergency work. He was budget, one set of rules and processes appointed Executive Director of WHO’s new Health and one clear line of authority. How Emergencies Programme at the level of Deputy will you do this with WHO’s governance Director-General last year. Before that, he held senior structure of seven entities: headquarters posts at the United Nations Children’s Fund (UNICEF) (HQ) plus six Regional Offices? including Regional Director for the Middle East and A: The programme has one work- North Africa, Global Coordinator for Ebola and Chief of force – and that is the critical point – one WHO set of people we can rely on in emergen- Peter Salama Global Health. Before joining UNICEF in 2002, Salama cies, whether they are at regional level was an epidemic intelligence service officer at the or at HQ, and, increasingly, we want International Emergency and Refugee Health Branch of the United States the heads of Country Offices to see Centers for Disease Control and Prevention, and a visiting professor in nutrition themselves as an integral part of the at Tufts University in the United States of America. He has worked with Médecins programme with the same philosophy, Sans Frontières and Concern Worldwide in Asia and sub-Saharan Africa.
    [Show full text]
  • Page 1 of 15 Mr Jean-Claude Juncker President European Commission Cc
    Mr Jean-Claude Juncker President European Commission cc: Frans Timmermans, First Vice-President, in charge of Better Regulation, Inter-Institutional Relations, the Rule of Law and the Charter of Fundamental Rights Andrus Ansip, Vice-President for the Digital Single Market Jyrki Katainen, Vice-President for Jobs, Growth, Investment and Competitiveness Maroš Šefčovič, Vice-President for the Energy Union Vytenis Andriukaitis, Commissioner for Health and Food Safety Elžbieta Bieńkowska, Commissioner for Internal Market, Industry, Entrepreneurship and SMEs Violeta Bulc, Commissioner for Transport Miguel Arias Cañete, Commissioner for Climate Action and Energy Corina Creţu, Commissioner for Regional Policy Carlos Moedas, Commissioner for Research, Science and Innovation Cecilia Malmström, Commissioner for Trade Pierre Moscovici, Commissioner for Economic and Financial Affairs, Taxation and Customs Tibor Navracsics, Commissioner for Education, Culture, Youth and Sport Günther Öttinger, Commissioner for Budget and Human Resources Marianne Thyssen, Commissioner for Employment, Social Affairs, Skills and Labour Mobility Karmenu Vella, Commissioner for Environment, Maritime Affairs and Fisheries Margrethe Vestager, Commissioner for Competition Brussels, 16 June 2017 Re: Contribute to economic growth and climate change mitigation through a EU Cycling Strategy Dear President Juncker, With this letter, signed by leaders from businesses, public authorities and civil society, we call upon the European Commission to unlock the potential for creating jobs
    [Show full text]
  • Ebola: Democratic Republic of Congo
    CRS INSIGHT Ebola: Democratic Republic of Congo Updated October 4, 2018 (IN10917) | Related Author Tiaji Salaam-Blyther | Tiaji Salaam-Blyther, Coordinator, Specialist in Global Health ([email protected], 7-7677) Monyai L. Chavers, Research Assistant ([email protected], 7-0829) On August 1, 2018, the World Health Organization (WHO) reported that a new Ebola outbreak was detected in the eastern part of the Democratic Republic of Congo (DRC), about one week after having declared that a separate outbreak had ended in the western part of the country. This new outbreak is occurring in North Kivu and Ituri provinces, the most populated provinces in DRC, where a humanitarian crisis affecting over 1 million displaced people is ongoing. Health workers have begun vaccinating people in the districts to control the spread of the disease, though armed conflict in the areas is complicating control efforts. As of October 2, 2018, 162 people have contracted Ebola in North Kivu and Ituri provinces (including 19 health workers), 106 of whom have died (3 of whom were health workers). This outbreak is the 10th Ebola outbreak in DRC since the disease was discovered in 1976, and it stands in stark contrast to the previous outbreak (Figure 1). The outbreak that began in May 2018 was contained and ended within two months after having infected 54 people, including 33 of whom died. In its second month, this outbreak has caused twice as many deaths and is continuing to spread. Issues complicating efforts to contain the current outbreak include the following: Conflict. In September 2018, clashes between rebels and government forces had forced WHO to temporarily suspend operations in Beni, the WHO operational base.
    [Show full text]
  • February 12, 2015 Commissioner Vytenis Andriukaitis European
    February 12, 2015 Commissioner Vytenis Andriukaitis European Commission Rue de la Loi 170 B-1049 Brussels Dear Commissioner, The undersigned organizations, representing a broad section of the U.S. food and agricultural industry, urge you and your colleagues to ensure that draft Decisions authorizing the importation for food and feed processing of thirteen new biotechnology products are considered by the College of Commissioners without further delay. All of these products (soy, maize, rapeseed, cotton) have received positive European Food Safety Authority (EFSA) scientific assessments and have been considered by the Standing Committee on the Food Chain and Animal Health and the Appeals Committee. The majority of these product applications were ready for adoption by the College of Commissioners last summer but, unfortunately, the outgoing College failed to act before its term expired. The length of time taken for EU decisions on new biotech crops has only increased in recent years, and the approval process for import files now appears to have come to a complete stop. The last import authorizations were issued by the European Commission in November 2013. Some of the pending products are already being grown in exporting countries under stewardship programs, and production volumes are increasing each growing season for domestic and export markets. Timely action by the European Commission will avoid the risk of disruption to the essential supply of feedstocks needed by the EU’s livestock, poultry and feed industries, which are more than 70 percent dependent on imported protein. The uncertainty and undue delays surrounding import approvals are creating unnecessary costs for producers and the agri-supply chain.
    [Show full text]
  • THE LITHUANIAN WORLD-WIDE DAILY Novambar 12
    3106 p GRATIS ? n REFERENS^F C^ESS "A3HIN6T0N OC 20025 UŽSIENIO LIETUVIŲ DIENRAŠTIS 4545 WEST 63rd STREET • CHICAGO, ILLINOIS 60629 TEL: 773-585-9500 • FAX: 773-585-8284 • DRAUGAS@EARTHUNICNET PERtOCHCALS THE LITHUANIAN WORLD-WIDE DAILY Novambar 12 . 1996 Nr. 221 VoL LXXXVI Kaina 50 c. ANTRADIENIS - TUESDAY, LAPKRITIS - NOVEMBER 12, 1996 Kas tarnaus Lietuvai Pasaulio naujienos ateinančius 4 metus? (Remiantis DPA, Reuter, BNS INTERFAX, ITAR-TASS, BelaPAN žinių agentūrų pranešimais) Vilnium, lapkričio 11 d. (BNS) Žvaliauskas, Vaclovas Lapė, - Rinkimų komisijai paskelbus Rytas Kupčinskas, Vladimiras Vašingtonas. Jungtinių Santiago. Lotynų Amerikos urminius rezultatus, galutinai Jarmolenko, Simas Petrikis, Valstijų Senato respublikonų valstybių bei Ispanijos ir Portu­ >aaiškėjo, kad didžiausią frak- Gražina Imbrasienė, Petras vadovas Trent Lott šeštadienį galijos valdovų susitikime Ku­ nją būsimajame Seime sudarys Šakalinis, Stasys Malkevičius, pažadėjo bendradarbiauti su an­ bos prezidentas Fidel Castro konservatorių frakcija, ture- Juozas Dringelis, Žibartas trai kadencijai perrinku JAV užsipuolė Jungtines Valstijas, lianti 70 narių. Tai nesudaro Jackūnas, Nijolė Ambrazaitytė, prezidentu Bill Clinton, jei jis kad šios, kišdamosis į Lotynų absoliučios daugumos 141 vietą Stasys Stačiokas, Algimantas nuoširdžiai sieks subalansuoti Amerikos valstybių reikalus, turinčiame Seime. Tačiau kon­ Sėjūnas, Juozas Galdikas, šalies biudžetą ir sumažinti vy­ žlugdo jų kultūrą. „Mūsų kul­ servatoriai tikrai turės daugu­ Vytautas Knašys, Vincas Gir­ riausybę. Lott šeštadienį pareiš­ tūrą žlugdo šio hegemono kont­ mą pavasarį, kai bus surengti nius, Romualdas Sikorskis, kė, jog respublikonai yra nusi­ roliuojamos visuomenės infor­ nauji rinkimai 4 apygardose, Alfredas Stasiulevičius, Al­ teikę užmiršti rinkimų kampa­ mavimo priemonės, tuo tarpu, kur jie neįvyko. girdas Petruševičius, Vladas nijos kartėlį ir pradėti dirbti kai ta pati valstybė organizuo­ kartu šalies labui.
    [Show full text]
  • THE JUNCKER COMMISSION: an Early Assessment
    THE JUNCKER COMMISSION: An Early Assessment John Peterson University of Edinburgh Paper prepared for the 14th Biennial Conference of the EU Studies Association, Boston, 5-7th February 2015 DRAFT: Not for citation without permission Comments welcome [email protected] Abstract This paper offers an early evaluation of the European Commission under the Presidency of Jean-Claude Juncker, following his contested appointment as the so-called Spitzencandidat of the centre-right after the 2014 European Parliament (EP) election. It confronts questions including: What will effect will the manner of Juncker’s appointment have on the perceived legitimacy of the Commission? Will Juncker claim that the strength his mandate gives him license to run a highly Presidential, centralised Commission along the lines of his predecessor, José Manuel Barroso? Will Juncker continue to seek a modest and supportive role for the Commission (as Barroso did), or will his Commission embrace more ambitious new projects or seek to re-energise old ones? What effect will British opposition to Juncker’s appointment have on the United Kingdom’s efforts to renegotiate its status in the EU? The paper draws on a round of interviews with senior Commission officials conducted in early 2015 to try to identify patterns of both continuity and change in the Commission. Its central aim is to assess the meaning of answers to the questions posed above both for the Commission and EU as a whole in the remainder of the decade. What follows is the proverbial ‘thought piece’: an analysis that seeks to provoke debate and pose the right questions about its subject, as opposed to one that offers many answers.
    [Show full text]
  • Mr Vytenis ANDRIUKAITIS European Commissioner for Health European Commission Rue De La Loi, 200 1049 Brussels
    Mr Vytenis ANDRIUKAITIS European Commissioner for Health European Commission Rue de la Loi, 200 1049 Brussels Ref: RB.RT.mcf/67.190 29 June 2015 Dear Commissioner, Following the meeting that my EFPIA colleagues and I had on 28 May 2015 with members of your cabinet in relation to the ongoing crisis in Greece, I am writing to follow up with more details on our concerns about what might happen within the medicines market in the event that Greece fails to reach a deal with its creditors and is forced to leave the Euro. In the worst-case scenario of ‘Grexit’, we believe the integrity of the medicines supply chain may be in jeopardy, which would create a risk to public health. As such we believe it prudent and responsible to ensure there is a dialogue between the Commission and the pharmaceutical industry on concrete contingency plans. There are two broad categories of issues that we believe may disrupt the supply of medicines under the Grexit scenario: 1. The first relates to the potential for general practical disruption in the operation of the business environment. Technical breakdown in infrastructure supporting transactions, uncertainty on the validity of contracts, coupled with general social unrest, is likely to lead to problems throughout the economy. The Greek medicines supply chain is complicated compared with other European member states and therefore we think that the medicines supply chain may be particularly vulnerable to the sort of disruption described here. We believe, for example, that several hundred wholesalers are involved in the purchase and distribution of medicines to Greek pharmacies (a supply chain that is much more fragmented than in other EU countries).
    [Show full text]
  • President High Representative
    First Vice-President High Representative Frans Timmermans Federica Mogherini Better Regulation, Inter-Institutional High Representative of the Union Relations, the Rule of Law and the for Foreign Affairs and Security Poli- Charter of Fundamental Rights cy / Vice-President of the PRESIDENT Commission Vice-President JEAN-CLAUDE JUNCKER Vice-President Kristalina Georgieva Andrus Ansip Vice-President Vice-President Budget & Human Resources Digital Single Market Vice-President Alenka Bratušek Valdis Dombrovskis Jyrki Katainen Energy Union Euro & Social Dialogue Jobs, Growth, Investment and Competitiveness Commissioner Commissioner Commissioner Commissioner Commissioner Commissioner Vĕra Jourová Günther Oettinger Pierre Moscovici Marianne Thyssen Corina Creţu Johannes Hahn Justice, Consumers and Gender Digital Economy & Society Economic and Financial Affairs, Employment, Social Affairs, Regional Policy European Neighbourhood Policy Equality Taxation and Customs Skills and Labour Mobility & Enlargement Negotiations Commissioner Commissioner Commissioner Commissioner Commissioner Commissioner Dimitris Avramopoulos Vytenis Andriukaitis Jonathan Hill Elżbieta Bieńkowska Miguel Arias Cañete Neven Mimica Financial Stability, Financial Services and Health & Food Safety Migration & Home Affairs Capital Markets Union Internal Market, Industry, Climate Action & Energy International Cooperation Entrepreneurship and SMEs & Development Commissioner Commissioner Commissioner Commissioner Margrethe Vestager Maroš Šefčovič Cecilia Malmström Karmenu Vella Competition Transport & Space Trade Environment, Maritime Affairs and Fisheries Commissioner Commissioner Commissioner Commissioner Tibor Navracsics Carlos Moedas Phil Hogan Christos Stylianides * The HRVP may ask the Commissioner Education, Culture, Youth and Research, Science Agriculture & Humanitarian Aid & (and other commissioners) to deputise Citizenship and Innovation Rural Development Crisis Management for her in areas related to Commission competence.
    [Show full text]
  • The GAVI Alliance
    GLOBAL PROGRAM REVIEW The GAVI Alliance Global Program Review The World Bank’s Partnership with the GAVI Alliance Main Report and Annexes Contents ABBREVIATIONS .................................................................................................................................. V ACKNOWLEDGMENTS ........................................................................................................................ XI PROGRAM AT A GLANCE: THE GAVI ALLIANCE ............................................................................ XII KEY BANK STAFF RESPONSIBLE DURING PERIOD UNDER REVIEW ........................................ XIV GLOSSARY ......................................................................................................................................... XV OVERVIEW ........................................................................................................................................ XVII GAVI ALLIANCE MANAGEMENT RESPONSE .............................................................................. XXV WORLD BANK GROUP MANAGEMENT RESPONSE ................................................................... XXIX CHAIRPERSON’S SUMMARY ......................................................................................................... XXXI 1. THE WORLD BANK-GAVI PARTNERSHIP AND THE PURPOSE OF THE REVIEW ...................... 1 Evolution of GAVI .....................................................................................................................................................
    [Show full text]
  • The Exacerbation of Ebola Outbreaks by Conflict in the Democratic Republic of the Congo
    The exacerbation of Ebola outbreaks by conflict in the Democratic Republic of the Congo Chad R. Wellsa,1, Abhishek Pandeya,1, Martial L. Ndeffo Mbahb, Bernard-A. Gaüzèrec, Denis Malvyc,d,e, Burton H. Singerf,2, and Alison P. Galvania aCenter for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06520; bDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843; cCentre René Labusquière, Department of Tropical Medicine and Clinical International Health, University of Bordeaux, 33076 Bordeaux, France; dDepartment for Infectious and Tropical Diseases, University Hospital Centre of Bordeaux, 33075 Bordeaux, France; eINSERM 1219, University of Bordeaux, 33076 Bordeaux, France; and fEmerging Pathogens Institute, University of Florida, Gainesville, FL 32610 Contributed by Burton H. Singer, September 9, 2019 (sent for review August 14, 2019; reviewed by David Fisman and Seyed Moghadas) The interplay between civil unrest and disease transmission is not recombinant vesicular stomatitis virus–Zaire Ebola virus vaccine well understood. Violence targeting healthcare workers and Ebola (13). The vaccination campaign not only played an important treatment centers in the Democratic Republic of the Congo (DRC) role in curtailing the epidemic expeditiously (14), it also facili- has been thwarting the case isolation, treatment, and vaccination tated public awareness of the disease and improved practice of efforts. The extent to which conflict impedes public health re- Ebola safety precautions (15). By contrast, the sociopolitical sponse and contributes to incidence has not previously been crisis in eastern DRC has hampered the contact tracing that is a evaluated.
    [Show full text]
  • Vytenis Andriukaitis
    VYTENIS ANDRIUKAITIS Personal details • Lithuanian • Born 9 August 1951, in Yakutsk Autonomous Republic, Russia (USSR) • Married with three children Education 1979 - 1984: Vilnius University, Faculty of History (Master’s degree and lecturer in history and political science) 1969 - 1975: Kaunas Institute of Medicine (medical doctor) Political career • 2012 - 2014: Minister of Health, Republic of Lithuania • 2014: Vice-President of the 67th World Health Assembly • 1992 - 2014: Member of Seimas, Parliament of the Republic of Lithuania, 6 consecutive terms • 2008 – 2012: Member, COSAC (Conference of Parliamentary Committees for Union Affairs of Parliaments of the European Union) • 2004 – 2008: Director, Institute of Social and Economic Studies • 2002 – 2003: Leader of the Lithuanian delegation to the Convention on the Future of Europe • 2001 – 2004: Deputy Speaker of the Seimas • 2001 – 2004: Chair, EU Affairs Committee of the Seimas • 2001 – 2002: Chair, Baltic Assembly • 2000 – 2004: Member of the PES Presidium and Council • 1999 – 2000: Chair, Lithuanian Social Democratic Party • 1994 – 1996: Member, Parliamentary Assembly of the Council of Europe’s Legal Affairs and Human Rights Committee • 1990 - 1992: Signatory to Act of Independence of the Republic of Lithuania and co-author of its Constitution • 1989 Founder of Social Democratic Party of Lithuania • 1969 – 1991: Actively involved in the anti-Soviet movement Medical career • 1975 – 1976: Medical doctor, Kaunas County Hospital • 1976 – 1984: Surgeon, Ignalina Central Hospital • 1985 – 1993: Cardio-surgeon, Vilnius Republic Clinical Hospital Awards: WHO World No Tobacco Day Award (2014), Commander’s Grand Cross of the Order of Lithuanian Grand Duke Gediminas (2004), Ordem do Mérito Grã-Cruz of the Portuguese Republic (2003) Publications: various legislative acts and amendments, contributions to the Convention on the Future of Europe, books and press articles on the history of medicine, surgery, political science and labor market organization.
    [Show full text]